跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

辛可尼丁

首页药物辛可尼丁

Investigational

Small Molecule

辛可尼丁

Cinchonidine

未知生产厂商

生成 AI 研报

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

技术标识符

化学式: C₁₉H₂₂N₂O
CAS 编号: 485-71-2
UNII ID: 1U622LRA8Z

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PROCESS FOR PRODUCING 4,5-DIHYDRO-1H-PYRAZOLES AND INTERMEDIATES
EP 4132912 A4申请人: INVERSAGO PHARMA INC优先权: 2020
CN
EP
US
WO
4 件公开
Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV
- US 8927722 B2
  申请人: HORVATH ANDRAS优先权: 2008
  US
  4 件公开
- US 9227965 B2
  申请人: JANSSEN PHARMACEUTICALS INC优先权: 2011
  CN
  US
  3 件公开
Method for resolving racemic mixtures of 5-substituted 4-hydroxy-2-furanones
US 2003065196 A1申请人: APPERE GEORGES优先权: 1999
US
2 件公开
Liquid crystal compounds, preparation thereof, and composition containing the same
US 7022259 B2申请人: IND TECH RES INST优先权: 2002
US
2 件公开
Amine Salts Of (-)-2-((2-(4-Hydroxyphenyl)Ethyl)Thio)-3-(4-(2-(4-((Methylsulfonyl)Oxy)Phenoxy)Ethyl)Phenyl) Propanoic Acid
US 2008090905 A1申请人: SNAPE EVAN W优先权: 2004
US
Optical separation method substituting oxyphosphonate acetate
CN 1955176 A申请人: SHANGHAI MEDICAL INDUSTRY INST优先权: 2005
CN
Optical active substitution oxyphosphonate salt acetate and its use
CN 1955185 A申请人: SHANGHAI MEDICAL INDUSTRY INST优先权: 2005
CN
Method for synthesizing cinchona alkaloids microwave radiation non-solvent
CN 101245063 A申请人: FOURTH MILITARY MEDICAL UNIV优先权: 2008
CN
Chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic carboxylate, preparation method and application thereof
CN 101357901 B申请人: UNIV HUNAN优先权: 2008
CN
Cinchonidine salt of (4S,5S)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-4,5-dihydro-1H-pyrazole-3-carboxylic acid, useful as intermediate in the preparation of cannabinoid CB1 neutral antagonists
EP 2314578 A1申请人: ESTEVE QUIMICA SA优先权: 2009
EP

第 1 / 2 页